Literature DB >> 6933489

Synthesis of enkephalins by adrenal medullary chromaffin cells: reserpine increases incorporation of radiolabeled amino acids.

S P Wilson, K J Chang, O H Viveros.   

Abstract

Adrenal medullary chromaffin cells maintained in a chemically defined, serum-free medium retain high levels of both catecholamines and opiate-like peptides. At least 25% of the opioid activity as measured by radioreceptor assay is present as [Met]- and [Leu]enkephalin. Incubation of chromaffin cells with [3H]tyrosine and [35S]methionine for 3 days results in incorporation of 3H and 35S into [Met]enkephalin and 3H incorporation into [Leu]enkephalin, demonstrating de novo enkephalin synthesis. Addition of 100 nM reserpine to the culture medium causes an 80% depletion of catecholamines and a 100% increase in opioid peptide content 3-4 days later. [Met]Enkephalin content is preferentially induced (290% above control) compared with [Leu]enkephalin (70%) Reserpine increases the fractional radiolabeling of [Met]- and [Leu]enkephalin in excess of control cultures, suggesting that the increase in opiate-like peptides results from an increased rate of synthesis rather than decreased degradation, decreased secretion, or increased processing of preformed precursor(s).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6933489      PMCID: PMC349835          DOI: 10.1073/pnas.77.7.4364

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Rat striatal methionine-enkephalin content after chronic treatment with cataleptogenic and noncataleptogenic antischizophrenic drugs.

Authors:  J S Hong; H Y Yang; W Fratta; E Costa
Journal:  J Pharmacol Exp Ther       Date:  1978-04       Impact factor: 4.030

2.  gamma endorphin, alpha endorphin and Met-enkephalin are formed extracellularly from lipotropin C fragment.

Authors:  B M Austen; D G Smyth; C R Snell
Journal:  Nature       Date:  1977-10-13       Impact factor: 49.962

3.  Mechanism of secretion from the adrenal medulla. VI. Effect of reserpine on the dopamine -hydroxylase and catecholamine content and on the buoyant density of adrenal storage vesicles.

Authors:  O H Viveros; L Arqueros; N Kirshner
Journal:  Mol Pharmacol       Date:  1971-07       Impact factor: 4.436

4.  Mechanism of secretion from the adrenal medulla. IV. The fate of the storage vesicles following insulin and reserpine administration.

Authors:  O H Viveros; L Arqueros; R J Connett; N Kirshner
Journal:  Mol Pharmacol       Date:  1969-01       Impact factor: 4.436

5.  Rat brain enkephalins: distribution and biosynthesis.

Authors:  H Y Yang; J S Hong; W Fratta; E Costa
Journal:  Adv Biochem Psychopharmacol       Date:  1978

Review 6.  Trans-synaptic enzyme induction.

Authors:  H Thoenen
Journal:  Life Sci       Date:  1974-01-16       Impact factor: 5.037

7.  Incorporation of labelled amino acids into the enkephalins.

Authors:  R P Sosa; A T McKnight; J Hughes; H W Kosterlitz
Journal:  FEBS Lett       Date:  1977-12-01       Impact factor: 4.124

8.  Radioimmunoassay and characterization of enkephalins in rat tissues.

Authors:  R J Miller; K J Chang; B Cooper; P Cuatrecasas
Journal:  J Biol Chem       Date:  1978-01-25       Impact factor: 5.157

9.  [Met5]Enkephalin content in brain regions of rats treated with lithium.

Authors:  J C Gillin; J S Hong; H Y Yang; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

10.  Functional and morphological characterization of isolated bovine adrenal medullary cells.

Authors:  E M Fenwick; P B Fajdiga; N B Howe; B G Livett
Journal:  J Cell Biol       Date:  1978-01       Impact factor: 10.539

View more
  17 in total

1.  Measurement of secretory vesicle pH reveals intravesicular alkalinization by vesicular monoamine transporter type 2 resulting in inhibition of prohormone cleavage.

Authors:  C G Blackmore; A Varro; R Dimaline; L Bishop; D V Gallacher; G J Dockray
Journal:  J Physiol       Date:  2001-03-15       Impact factor: 5.182

2.  Role of enzymes and inhibitors in leu-enkephalin metabolism in rabbit and human plasma.

Authors:  F Bolacchi; M Marini; A Urbani; L Bongiorno; L G Roda
Journal:  Neurochem Res       Date:  1996-08       Impact factor: 3.996

Review 3.  The enkephalin-containing cell: strategies for polypeptide synthesis and secretion throughout the neuroendocrine system.

Authors:  L E Eiden
Journal:  Cell Mol Neurobiol       Date:  1987-12       Impact factor: 5.046

4.  Immunohistochemical localisation of substances reactive to antisera against alpha- and beta-endorphin and met-enkephalin in the brain of Rana temporaria L.

Authors:  J Doerr-Schott; M P Dubois; C Lichte
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

Review 5.  Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions.

Authors:  Lloyd D Fricker; Elyssa B Margolis; Ivone Gomes; Lakshmi A Devi
Journal:  Mol Pharmacol       Date:  2020-06-02       Impact factor: 4.436

6.  Enzymes and inhibitors in leu-enkephalin in metabolism in human plasma.

Authors:  F Bolacchi; M Marini; A Urbani; L G Roda
Journal:  Neurochem Res       Date:  1995-09       Impact factor: 3.996

7.  Studies with [35S]methionine indicate that the 22,000-dalton [Met]enkephalin-containing protein in chromaffin cells is a precursor of [Met]enkephalin.

Authors:  J Rossier; J M Trifaró; R V Lewis; R W Lee; A Stern; S Kimura; S Stein; S Udenfriend
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

8.  Tetrahydrobiopterin increases in adrenal medulla and cortex: a factor in the regulation of tyrosine hydroxylase.

Authors:  M M Abou-Donia; O H Viveros
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

9.  Localisation of oxytocin, vasopressin and parts of precursors in the human neonatal adrenal.

Authors:  R Ravid; H P Oosterbaan; B L Hansen; D F Swaab
Journal:  Histochemistry       Date:  1986

10.  Appearance of enkephalin-immunoreactivity in rat adrenal medulla following treatment with nicotinic antagonists or reserpine.

Authors:  M C Bohn; J A Kessler; L Golightly; I B Black
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.